Clarus Lifesciences II, L.P.

10% owner at NanoString Technologies Inc; 10% owner at IVERIC bio, Inc.; 10% owner at ACHILLION PHARMACEUTICALS INC

Sold, on record
$54.6M
Dollars the filings state
Form 4 sales
4
Latest Mar 22, 2019
Form 144 notices
0
Proposed sales
Companies
3
Filed as an executive or holder

Companies

Sales by reason

0
Routine
3
Plan not stated
0
No plan
1
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. Mar 22, 2019Unusual

    NanoString Technologies Inc

    Sold 49.6% of their holdings

    $43.2M2M shares at $21.62

    Filed Mar 22, 2019Form 4

  2. Jun 11, 2014Plan not stated

    IVERIC bio, Inc.

    Sold 6.9% of their holdings

    $9.6M211,680 shares at $45.42

    Filed Jun 11, 2014Form 4

  3. Dec 23, 2009Plan not stated

    ACHILLION PHARMACEUTICALS INC

    Sold 5.7% of their holdings

    $1M284,000 shares at $3.69

    Filed Dec 23, 2009Form 4

  4. Dec 18, 2009Plan not stated

    ACHILLION PHARMACEUTICALS INC

    Sold 4% of their holdings

    $731k207,176 shares at $3.53

    Filed Dec 18, 2009Form 4

4 of 4

Every transaction

Every transaction on a Form 4 or Form 5 by Clarus Lifesciences II, L.P.
TradedFiledStockRoleWhatAmountPriceValueHeld afterSource
Mar 22, 2019Mar 22, 2019NanoString Technologies Inc10% ownerSold2M$21.62$43.2M2MSEC
Jan 1, 2018Jan 3, 2018NanoString Technologies Inc10% ownerAwardedCommon Stock10,16810,168SEC
Jan 1, 2017Jan 4, 2017NanoString Technologies Inc10% ownerAwardedStock Option (Right to Buy)8,6118,611SEC
Jan 1, 2016Jan 5, 2016NanoString Technologies Inc10% ownerAwardedStock Option (Right to Buy)7,8287,828SEC
Jan 1, 2015Jan 5, 2015NanoString Technologies Inc10% ownerAwardedStock Option (Right to Buy)7,3077,307SEC
Jun 11, 2014Jun 11, 2014IVERIC bio, Inc.10% ownerSold211,680$45.42$9.6M4,500SEC
Dec 23, 2009Dec 23, 2009ACHILLION PHARMACEUTICALS INC10% ownerSold284,000$3.69$1M4.7MSEC
Dec 18, 2009Dec 18, 2009ACHILLION PHARMACEUTICALS INC10% ownerSold207,176$3.53$731k5MSEC

Sales and notices (4)

Form 144 notices and Form 4 sales by Clarus Lifesciences II, L.P.
Source
Mar 22, 2019Mar 22, 2019NanoString Technologies Inc10% ownerForm 4 sale2M$43.2M49.6%UnusualSEC
Jun 11, 2014Jun 11, 2014IVERIC bio, Inc.10% ownerForm 4 sale211,680$9.6M6.9%Plan not statedSEC
Dec 23, 2009Dec 23, 2009ACHILLION PHARMACEUTICALS INC10% ownerForm 4 sale284,000$1M5.7%Plan not statedSEC
Dec 18, 2009Dec 18, 2009ACHILLION PHARMACEUTICALS INC10% ownerForm 4 sale207,176$731k4.0%Plan not statedSEC